Kenichi Watanabe
Sapporo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Correction: Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2- advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study).
Journal: Breast cancer (Tokyo, Japan)
Published: January 27, 2026
Sacituzumab govitecan in Japanese participants with HR+/HER2- metastatic breast cancer: primary results from the phase II ASCENT-J02 study.
Journal: Japanese journal of clinical oncology
Published: December 11, 2025
Radiofrequency Ablation for Early Stage Breast Cancer as a Potential Alternative to Partial Mastectomy: 5-Year Results from the Multiple-Center, Single-Arm, Phase 3 RAFAELO Study (NCCH1409).
Journal: Annals of surgical oncology
Published: October 28, 2025
Proton-pump inhibitors and palbociclib or abemaciclib in endocrine-sensitive breast cancer treatment.
Journal: Scientific reports
Published: October 09, 2025
Management of Severe Abemaciclib-induced Liver Dysfunction: Feasibility of Switching to Palbociclib.
Management of Severe Abemaciclib-induced Liver Dysfunction: Feasibility of Switching to Palbociclib.
Journal: In vivo (Athens, Greece)
Published: September 18, 2025
Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trial.
Journal: Breast cancer (Tokyo, Japan)
Published: September 16, 2025
Efficacy and risks of drug holiday in the management of medication-related osteonecrosis of the jaw in cancer patients: a single-center retrospective study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: September 14, 2025
Pembrolizumab for Early-Stage Triple-Negative Breast Cancer: KEYNOTE-522 Japan Subgroup Analysis.
Journal: Cancer science
Published: September 08, 2025
Real-world outcomes of palbociclib plus endocrine therapy in elderly patients with HR+/HER2- advanced breast cancer in Japan: a subgroup analysis of the P-BRIDGE study by age group.
Journal: Breast cancer (Tokyo, Japan)
Published: August 18, 2025
Prediction of Severe Anemia and Neutropenia Induced by Abemaciclib in Patients With Breast Cancer.
Journal: Anticancer research
Published: March 24, 2025
Primary tumour resection plus systemic therapy versus systemic therapy alone in metastatic breast cancer (JCOG1017, PRIM-BC): a randomised clinical trial.
Journal: British journal of cancer
Published: March 06, 2025
Last Updated: 09/26/2026